HOME >> BIOLOGY >> NEWS
Study points to new way to predict death risk from torn aorta

ANN ARBOR, Mich. -- Each year, 10,000 Americans suffer a sudden tear in the lining of their bodys largest blood vessel, the aorta. Its often misdiagnosed, and it can kill if not treated immediately. Actor John Ritter died of such a tear in 2003.

Better medical imaging and treatments such as medication, surgery and catheter-based procedures are now giving more patients a chance to survive this crisis, called aortic dissection. But once they leave the hospital, patients face a one-in-four chance of dying within a few years. And doctors dont have a reliable way of predicting who is most at risk of dying, and who might benefit most from surgery or other treatment.

Now, a study published in the July 26 New England Journal of Medicine by an international team of researchers may offer hope for aortic dissection survivors, and give guidance for their physicians. The researchers, led by University of Michigan Cardiovascular Center experts, propose a new way to predict post-hospital death risk for aortic dissection patients, and a new model for the mechanism behind that risk.

Their model focuses on a phenomenon that can easily be seen on modern medical-imaging scans: the presence of blood clots in the channel created when the layers of the aorta separate like two layers of an onion. This channel, called the false lumen, runs alongside the true lumen, which is the hollow middle area of the aorta that acts as the pipeline for blood to flow out of the heart and down through the abdomen.

As blood enters the false lumen from the top of the tear in the aorta, it gets trapped inside the new channel. Often, small openings at the bottom of the newly formed channel will allow the blood to flow out. But if the openings arent large, blood flow inside the false lumen is slowed down, pressure increases, and clots begin to form.

The study shows that the risk of post-hospital death is more than two-and-a-half times greater for patient
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
25-Jul-2007


Page: 1 2 3 4 5

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study identifies new gene therapy tools for inherited blindness
6. Study finds contaminated water reaching Floridas offshore keys
7. Study sheds light on why humans walk on two legs
8. Study explains how pathogens evolve to escape detection
9. Study finds hereditary link to premenstrual depression
10. Study identifies energy efficiency as reason for evolution of upright walking
11. Study shows cane sugar, corn sweeteners have similar effects on appetite

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2019)... ... ... R3 Stem Cell is now offering its comprehensive Online Stem Cell Training ... during checkout is FIFTYOFF and applies to both the one month access and the ... over 12,000 successful stem cell procedures performed nationwide. A couple years ago, R3 began ...
(Date:11/6/2019)... ... 06, 2019 , ... In October, Massachusetts stem cell biotechnology ... about a poorly disclosed deficiency in stem cell treatments. Throughout stem cell ... treating stem cells. This problem affects all patients receiving stem cell treatments, ...
(Date:11/5/2019)... ... November 05, 2019 , ... Catalent, the leading global provider ... and consumer health products, today announced it will present at the upcoming World ... 12 – 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... , ... December 03, 2019 , ... A new survey ... Health, Teleflex, and CONMED as the overall best medical sales companies to work for ... Sales survey polled over 1,200 professionals from the MedReps community to identify which ...
(Date:12/4/2019)... , ... December 04, 2019 , ... ... further enhance dissolution and stabilize amorphous materials. Additionally, their PDF Synchrotron methods provide ... ability to describe these compositions both in regulatory and patent applications.  , The ...
(Date:11/22/2019)... ... November 22, 2019 , ... Modality Solutions, ... cold chain validation guide to meet and exceed increasingly stringent regulatory expectations ... biopharmaceutical industry leaders, the September 19, 2019 webinar was well received and ...
(Date:11/12/2019)... ... November 12, 2019 , ... REPROCELL ... have been selected by Lantern Pharma to provided preclinical screening and drug sensitivity ... of data points using panels of unique and genetically edited cell lines from ...
Breaking Biology Technology:
Cached News: